Bottom line
Is SELV a good fund? The bottom line
SELV is a managed large blend ETF from SEI.
Its expense ratio is 0.15% — about $15 a year on every $10,000 invested, cheaper than 95% of large blend funds we track.
It returned +12.8% over one year (as of Dec 31, 2025, per its prospectus).
With $245 million in net assets and 78 holdings, its largest position is Cardinal Health, Inc. (3.2%) and the top 10 make up 27.5% of the portfolio.
What stands out
- Low cost: cheaper than 95% of large blend peers
Updated Nov 19, 2026
What SELV invests in
Long-term capital appreciation with lower volatility relative to the broad U.S. large cap equity market.
"Under normal circumstances, the Fund will invest at least 80% of its net assets (plus the amount of any borrowings for investment purposes) in equity and equity-related securities (such as convertible bonds, convertible preferred stock, depositary receipts, warrants and rights) issued by large U.S. companies. The Fund seeks to provide long-term capital appreciation by investing primarily in U.S. common stocks, while aiming to experience lower volatility compared to the broad U.S. large cap equity market. SIMC uses a quantitative-based, active stock selection investment process to construct the Fund's portfolio, utilizing a combination of factor scoring model, risk model and optimization. The factor scoring model evaluates all of the securities in the investment universe of U.S. large-capitalization stocks based on measures of Value, Momentum, Quality and Low Volatility factor…
From the fund's prospectus (filed Jul 29, 2026).
SELV performance
| 1 yr | 5 yr | 10 yr | |
|---|---|---|---|
| SELV | +12.8% | — | — |
| Large Blend median | +13.8% | +9.7% | +10.9% |
Source: Fund prospectus, as of Dec 31, 2025
What SELV costs
On a $10,000 investment, SELV's 0.15% expense ratio costs about $15 a year. The prospectus estimates $192 in total costs over 10 years (assuming 5% annual returns). The median large blend fund charges 0.83%.
SELV top 10 holdings
| # | Holding | % of fund |
|---|---|---|
| 1 | Cardinal Health, Inc. | 3.17% |
| 2 | Johnson & Johnson | 3.14% |
| 3 | Cisco Systems, Inc. | 2.98% |
| 4 | Apple Inc. | 2.83% |
| 5 | Alphabet Inc. | 2.75% |
| 6 | Walmart Inc. | 2.74% |
| 7 | Merck & Co., Inc. | 2.66% |
| 8 | Gilead Sciences, Inc. | 2.52% |
| 9 | Altria Group, Inc. | 2.43% |
| 10 | Mckesson Corporation | 2.34% |
Source: SEC Form N-PORT, period ended Jun 30, 2026
The top 10 make up 27.5% of the fund. See all top 25 holdings and asset mix →